Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Zhonghua Yi Xue Za Zhi ; 103(11): 822-828, 2023 Mar 21.
Article in Chinese | MEDLINE | ID: mdl-36925115

ABSTRACT

Objective: To compare the clinical efficacy of a new generation of ligaments (LARS artificial ligament) and bone-patellar tendon-bone (BPTB) autograft as grafts in anterior cruciate ligament (ACL) revision. Methods: A retrospective cohort study. The clinical data of 54 patients who underwent ACL revision from January 2018 to June 2020 in the First Hospital Affiliated to Army Medical University were retrospectively analyzed. There were 44 males and 10 females with a mean age of (28.5±7.7) years (15-45 years). Among them, 24 cases underwent ACL revision with LARS artificial ligament (LARS group), the other 30 cases underwent ACL revision with BPTB (BPTB group). The subjective and objective knee joint evaluation indexes were compared between the two groups to evaluate the clinical efficacy. The subjective evaluation indexes included Tegner score, Lysholm score and the International Knee Documentation Committee (IKDC) score. The objective evaluation indexes included the Lachman test, pivot-shift test, the anterior tibial translation (ATT) measurement at the weight-bearing position and the rate of patients returned to pre-injury sports. Results: The follow-up period was (32.8±5.3) months (24-42 months). At the last follow-up, the IKDC score, Tegner score and Lysholm score in the two groups significantly increased when compared with those before surgery (all P<0.05), and there was no significant difference in those indexes between the two groups (all P>0.05). The ATT measurement in the weight-bearing position was (3.1±0.7) mm in the LARS group and it was (4.1±0.9) mm in the BPTB group, which were significantly improved when compared with those before surgery (both P<0.05), and it was better in the LARS group than in the BPTB group (P<0.05). Postoperative Lachman test and pivot-shift test results in the LARS group were better than those in the BPTB group with statistically significant difference (both P<0.05). The rate of patients returned to pre-injury sports one year after surgery was 79.2%(19/24) in the LARS group and it was 50.0%(15/30) in the BPTB group, and the difference was statistically significant (P=0.029). Conclusions: Both LARS artificial ligament and BPTB autograft can achieve good short-term clinical efficacy in ACL revision, but LARS artificial ligament group has more advantages than BPTB autograft group in knee stability and early return to sports.


Subject(s)
Anterior Cruciate Ligament Injuries , Anterior Cruciate Ligament Reconstruction , Patellar Ligament , Male , Female , Humans , Young Adult , Adult , Anterior Cruciate Ligament , Patellar Ligament/surgery , Retrospective Studies , Autografts/surgery , Anterior Cruciate Ligament Reconstruction/methods , Bone-Patellar Tendon-Bone Grafting/methods , Anterior Cruciate Ligament Injuries/surgery , Transplantation, Autologous , Treatment Outcome
2.
Sci Rep ; 12(1): 15565, 2022 Sep 16.
Article in English | MEDLINE | ID: mdl-36114218

ABSTRACT

Geographic atrophy (GA) is a vision-threatening manifestation of age-related macular degeneration (AMD), one of the leading causes of blindness globally. Objective, rapid, reliable, and scalable quantification of GA from optical coherence tomography (OCT) retinal scans is necessary for disease monitoring, prognostic research, and clinical endpoints for therapy development. Such automatically quantified biomarkers on OCT are likely to further elucidate structure-function correlation in GA and thus the pathophysiological mechanisms of disease development and progression. In this work, we aimed to predict visual function with machine-learning applied to automatically acquired quantitative imaging biomarkers in GA. A post-hoc analysis of data from a clinical trial and routine clinical care was conducted. A deep-learning automated segmentation model was applied on OCT scans from 476 eyes (325 patients) with GA. A separate machine learning prediction model (Random Forest) used the resultant quantitative OCT (qOCT) biomarkers to predict cross-sectional visual acuity under standard (VA) and low luminance (LLVA). The primary outcome was regression coefficient (r2) and mean absolute error (MAE) for cross-sectional VA and LLVA in Early Treatment Diabetic Retinopathy Study (ETDRS) letters. OCT parameters were predictive of VA (r2 0.40 MAE 11.7 ETDRS letters) and LLVA (r2 0.25 MAE 12.1). Normalised random forest feature importance, as a measure of the predictive value of the three constituent features of GA; retinal pigment epithelium (RPE)-loss, photoreceptor degeneration (PDR), hypertransmission and their locations, was reported both on voxel-level heatmaps and ETDRS-grid subfields. The foveal region (46.5%) and RPE-loss (31.1%) had greatest predictive importance for VA. For LLVA, however, non-foveal regions (74.5%) and PDR (38.9%) were most important. In conclusion, automated qOCT biomarkers demonstrate predictive significance for VA and LLVA in GA. LLVA is itself predictive of GA progression, implying that the predictive qOCT biomarkers provided by our model are also prognostic.


Subject(s)
Geographic Atrophy , Biomarkers , Cross-Sectional Studies , Geographic Atrophy/diagnostic imaging , Humans , Machine Learning , Tomography, Optical Coherence/methods
3.
Opt Express ; 26(11): 13865-13875, 2018 May 28.
Article in English | MEDLINE | ID: mdl-29877432

ABSTRACT

The optical limiting properties of alloyed Cd0.5Zn0.5S quantum dots associated with erythrosine dye are analyzed using 532 nm, 40 ps pulses. We show that joint influence of saturable absorption, reverse saturable absorption and two-photon absorption cause the optical limiting of 532 nm radiation at the pulse energies exceeding 1 mJ. The nonlinear refraction and nonlinear absorption of these quantum dots associated with different organic dyes were studied using 1064 nm and 532 nm radiation. The nonlinear refraction index and nonlinear absorption coefficient of Cd0.5Zn0.5S quantum dots were measured at λ = 1064 nm to be 2 × 10-13 cm2 W-1 and 1.2 × 10-8 cm W-1, while the reverse saturable absorption of Cd0.5Zn0.5S quantum dots and erythrosine at λ = 532 nm was almost two orders larger. The potential applications of these quantum dots for high-order harmonic generation are discussed.

4.
Genet Mol Res ; 15(2)2016 May 23.
Article in English | MEDLINE | ID: mdl-27323075

ABSTRACT

MicroRNAs (miRs) are associated with tumor progression in various cancers, such as gastric and hepatic carcinomas, and lung cancer. miR-301a is overexpressed and displays oncogenic activity in cancers. We investigated the biological involvement of miR-301a in osteosarcoma (OS). Quantitative real-time polymerase chain reaction (qRT-PCR) was used to analyze expression levels of miR-301a in 24 OS and matched adjacent non-tumor tissues. A miR-301a mimic was transferred into OS cell lines U-2 OS and MG-63 to upregulate miR-301a. The effects of miR-301a were investigated by examining cell proliferation, migration, and the cell cycle. The miR-301 target was predicted by TargetScan and confirmed by western blotting and qRT-PCR. The expression of miR-301a was significantly higher in OS tissues compared with the matched adjacent non-tumor tissues (0.959 ± 0.39 vs 3.9516 ± 1.18). Upregulated miR-301a significantly increased proliferation at 48 and 72 h compared to the negative control (U-2 OS: 2.11 ± 0.21 vs 2.88 ± 0.24; 2.70 ± 0.26 vs 3.71 ± 0.24; MG-63: 2.19 ± 0.20 vs 3.19 ± 0.22; 3.1 ± 0.25 vs 4.01 ± 0.27) and migration capability (U-2 OS: 100 ± 20.19 vs 150.68 ± 32.83; MG-63: 100 ± 17.20 vs 133.35 ± 26.26), and decreased apoptosis in both U-2 OS (10.87 ± 2.53 vs 4.01 ± 2.23) and MG-63 (15.26 ± 2.15 vs 8.25 ± 3.07). The cell cycle studies revealed that miR-301a caused an increase of the G2 population in U-2 OS (38.6 ± 6.58 vs 47.2 ± 7.27) and MG-63 (44.01 ± 5.28 vs 57.9 ± 4.25). Additional experiments indicated that CDC14A was upregulated by miR-301a (0.63 ± 0.06 vs 0.98 ± 0.06; 1.49 ± 0.25 vs 2.99 ± 0.14). Overexpressed miR-301a may increase CDC14A expression and promote cell proliferation and migration in OS cells. Therefore, miR- 301a may be useful for osteosarcoma diagnosis and therapy.


Subject(s)
Carcinogenesis/genetics , MicroRNAs/biosynthesis , Osteosarcoma/genetics , Phosphoric Monoester Hydrolases/biosynthesis , Apoptosis/genetics , Cell Cycle/genetics , Cell Line, Tumor , Cell Movement/genetics , Cell Proliferation/genetics , Female , Gene Expression Regulation, Neoplastic , Humans , Male , MicroRNAs/genetics , Osteosarcoma/pathology , Phosphoric Monoester Hydrolases/genetics , Protein Tyrosine Phosphatases , Transcriptional Activation/genetics
5.
J Med Econ ; 18(8): 629-36, 2015.
Article in English | MEDLINE | ID: mdl-25800457

ABSTRACT

OBJECTIVE: The objective of this economic model was to estimate the difference in medical costs among patients treated with paliperidone palmitate once-monthly injectable antipsychotic (PP1M) vs placebo, based on clinical event rates reported in the 15-month randomized, double-blind, placebo-controlled, parallel-group study of paliperidone palmitate evaluating time to relapse in subjects with schizoaffective disorder. RESEARCH DESIGN AND METHODS: Rates of psychotic, depressive, and/or manic relapses and serious and non-serious treatment-emergent adverse events (TEAEs) were obtained from the long-term paliperidone palmitate vs placebo relapse prevention study. The total annual medical cost for a relapse from a US payer perspective was obtained from published literature and the costs for serious and non-serious TEAEs were based on Common Procedure Terminology codes. Total annual medical cost differences for patients treated with PP1M vs placebo were then estimated. Additionally, one-way and Monte Carlo sensitivity analyses were conducted. RESULTS: Lower rates of relapse (-18.3%) and serious TEAEs (-3.9%) were associated with use of PP1M vs placebo as reported in the long-term paliperidone palmitate vs placebo relapse prevention study. As a result of the reduction in these clinical event rates, the total annual medical cost was reduced by $7140 per patient treated with PP1M vs placebo. One-way sensitivity analysis showed that variations in relapse rates had the greatest impact on the estimated medical cost differences (range: -$9786, -$4670). Of the 10,000 random cycles of Monte Carlo simulations, 100% showed a medical cost difference <$0 (reduction) for patients using PPIM vs placebo. The average total annual medical differences per patient were -$8321 for PP1M monotherapy and -$6031 for PPIM adjunctive therapy. CONCLUSIONS: Use of PP1M for treatment of patients with schizoaffective disorder was associated with a significantly lower rate of relapse and a reduction in medical costs compared to placebo. Further evaluation in the real-world setting is warranted.


Subject(s)
Antipsychotic Agents/economics , Antipsychotic Agents/therapeutic use , Paliperidone Palmitate/economics , Paliperidone Palmitate/therapeutic use , Psychotic Disorders/drug therapy , Antipsychotic Agents/administration & dosage , Antipsychotic Agents/adverse effects , Cost-Benefit Analysis , Delayed-Action Preparations , Dose-Response Relationship, Drug , Double-Blind Method , Humans , Injections, Intramuscular , Paliperidone Palmitate/administration & dosage , Paliperidone Palmitate/adverse effects , Secondary Prevention
6.
Int J Clin Pract ; 68(12): 1514-22, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25358867

ABSTRACT

BACKGROUND: To assess the tardive dyskinesia (TD) rate in studies of once-monthly long-acting injectable (LAI) paliperidone palmitate (PP) and once-daily oral paliperidone extended release (Pali ER). METHODS: Completed schizophrenia and bipolar studies for PP and Pali ER (≥ 6 month duration with retrievable patient-level data) were included in this post hoc analysis. Schooler-Kane research criteria were applied using Abnormal Involuntary Movement Scale (AIMS) scores to categorise probable (qualifying AIMS scores persisting for ≥ 3 months) and persistent TD (score persisting ≥ 6 months). Spontaneously reported TD adverse events (AEs) were also summarised. Impact of exposure duration on dyskinesia (defined as AIMS total score ≥ 3) was assessed by summarising the monthly dyskinesia rate. RESULTS: In the schizophrenia studies, TD rates for PP (four studies, N = 1689) vs. Pali ER (five studies, N = 2054), were: spontaneously reported AE, 0.18% (PP) vs. 0.10% (Pali ER); probable TD, 0.12% (PP) vs. 0.19% (Pali ER) and persistent TD, 0.12% (PP) vs. 0.05% (Pali ER). In the only bipolar study identified [Pali ER (N = 614)], TD rate was zero (spontaneously reported AE reporting, probable and persistent TD assessments). Dyskinesia rate was higher within the first month of treatment with both PP (13.1%) and Pali ER (11.7%) and steadily decreased over time (months 6-7: PP: 5.4%; Pali ER: 6.4%). Mean exposure: PP, 279.6 days; Pali ER, 187.2 days. CONCLUSIONS: Risk of TD with paliperidone was low (< 0.2%), regardless of the formulation (oral or LAI), in this clinical trial dataset. Longer cumulative exposure does not appear to increase the risk of dyskinesias.


Subject(s)
Antipsychotic Agents/adverse effects , Movement Disorders/epidemiology , Paliperidone Palmitate/adverse effects , Risperidone/adverse effects , Adult , Antipsychotic Agents/administration & dosage , Antipsychotic Agents/therapeutic use , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/therapeutic use , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Middle Aged , Movement Disorders/drug therapy , Movement Disorders/etiology , Paliperidone Palmitate/pharmacology , Paliperidone Palmitate/therapeutic use , Recurrence , Risperidone/therapeutic use , Schizophrenia/drug therapy , Treatment Outcome
7.
Sci Rep ; 4: 4682, 2014 May 15.
Article in English | MEDLINE | ID: mdl-24828016

ABSTRACT

The morphological disparity of lophotrochozoan phyla makes it difficult to predict the morphology of the last common ancestor. Only fossils of stem groups can help discover the morphological transitions that occurred along the roots of these phyla. Here, we describe a tubular fossil Yuganotheca elegans gen. et sp. nov. from the Cambrian (Stage 3) Chengjiang Lagerstätte (Yunnan, China) that exhibits an unusual combination of phoronid, brachiopod and tommotiid (Cambrian problematica) characters, notably a pair of agglutinated valves, enclosing a horseshoe-shaped lophophore, supported by a lower bipartite tubular attachment structure with a long pedicle with coelomic space. The terminal bulb of the pedicle provided anchorage in soft sediment. The discovery has important implications for the early evolution of lophotrochozoans, suggesting rooting of brachiopods into the sessile lophotrochozoans and the origination of their bivalved bauplan preceding the biomineralization of shell valves in crown brachiopods.


Subject(s)
Invertebrates/anatomy & histology , Invertebrates/physiology , Animals , Biological Evolution , China , Fossils , Phylogeny
8.
J Bacteriol ; 183(19): 5709-17, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11544234

ABSTRACT

Streptococcus pneumoniae is among the most significant causes of bacterial disease in humans. Here we report the 2,038,615-bp genomic sequence of the gram-positive bacterium S. pneumoniae R6. Because the R6 strain is avirulent and, more importantly, because it is readily transformed with DNA from homologous species and many heterologous species, it is the principal platform for investigation of the biology of this important pathogen. It is also used as a primary vehicle for genomics-based development of antibiotics for gram-positive bacteria. In our analysis of the genome, we identified a large number of new uncharacterized genes predicted to encode proteins that either reside on the surface of the cell or are secreted. Among those proteins there may be new targets for vaccine and antibiotic development.


Subject(s)
Genome, Bacterial , Sequence Analysis, DNA , Streptococcus pneumoniae/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , DNA Transposable Elements/genetics , Humans , Molecular Sequence Data
9.
Proc Natl Acad Sci U S A ; 96(18): 10016-20, 1999 Aug 31.
Article in English | MEDLINE | ID: mdl-10468554

ABSTRACT

Silicon chips with immobilized target DNAs were used for accurate genotyping by mass spectrometry. Genomic DNAs were amplified with PCR, and the amplified products were covalently attached to chip wells via N-succinimidyl (4-iodoacetyl)aminobenzoate (SIAB) chemistry. Primer annealing, extension, and termination were performed on a 1-microl scale directly in the chip wells in parallel. Diagnostic products thus generated were detected in situ by using matrix-assisted laser desorption ionization mass spectrometry. This miniaturized method has the potential for accurate, high-throughput, low-cost identification of genetic variations.


Subject(s)
DNA/chemistry , DNA/genetics , Genotype , Polymerase Chain Reaction/methods , Silicon , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Base Sequence , Cross-Linking Reagents , DNA Primers , Microscopy, Electron, Scanning/methods , Succinimides
10.
Nat Biotechnol ; 16(4): 381-4, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9555731

ABSTRACT

Matrix-assisted laser desorption ionization time of flight mass spectrometry was used to sequence exons 5 to 8 of the human p53 gene. A single tube procedure was established for target amplification and mass spectrometric (MS) sequencing. The MS sequencing scheme is designed for high throughput and parallel sample processing, and is amenable to full automation. Reliable sequencing data were obtained using fmol sample amounts. The high resolution and accuracy of MS sequencing was demonstrated by direct sequencing of a heterozygous template.


Subject(s)
Exons , Genes, p53 , Base Sequence , DNA , Genetic Carrier Screening , Humans , Mutation , Polymerase Chain Reaction , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
11.
Nucleic Acids Res ; 25(3): 677-9, 1997 Feb 01.
Article in English | MEDLINE | ID: mdl-9016613

ABSTRACT

Duplex probes with five base single-stranded overhangs can capture dsDNA targets from type IIS restriction nuclease digests. Ligation generates a predesigned nick site, where DNA polymerase can generate sequencing ladders by strand displacement or nick translation in the presence of trace amounts of dideoxynucleotides. This allows dsDNA targets to be captured from mixtures and directly sequenced without subcloning, purification or denaturation.


Subject(s)
Sequence Analysis, DNA , Base Sequence , Molecular Sequence Data
12.
Nat Biotechnol ; 14(9): 1123-8, 1996 Sep.
Article in English | MEDLINE | ID: mdl-9631064

ABSTRACT

Two methods of solid-phase Sanger DNA sequencing followed by detection with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry are demonstrated. In one method, sequencing ladders generated on an immobilized synthetic template were resolved up to the 63-mer including the primer. Detection sensitivity and resolution were sufficient for sequence analysis in the given range. This approach is particularly suitable for comparative (diagnostic) DNA sequencing. A second method that has the potential for high throughput de novo DNA sequencing is also presented; it uses immobilized duplex probes with five-base single-stranded overhangs to capture an unknown DNA template serving as primers for Sanger DNA sequencing. The power of mass spectrometry is demonstrated not only by its very high speed, but also by its ability to identify sequences that are not readable using gel electrophoresis.


Subject(s)
Sequence Analysis, DNA/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Base Sequence , Biotechnology , DNA/genetics , DNA Primers/genetics , Evaluation Studies as Topic , Molecular Sequence Data , Sensitivity and Specificity , Sequence Analysis, DNA/statistics & numerical data , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/statistics & numerical data
13.
Genet Anal ; 12(3-4): 137-42, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8673738

ABSTRACT

Duplex probes with five-base single-stranded overhangs were developed for positional sequencing by hybridization [Broude et al., Proc Natl Acad Sci USA 91:3072-3076, 1994]. The partially duplex probes can be employed to capture single-stranded oligonucleotide targets and form primer-template complexes. Recently we showed that partially duplex probes can prime Sanger sequencing reactions on immobilized, but non-ligated long single-stranded targets (approximately 500 nucleotide) [Fu et al., Proc Natl Acad Sci, in press]. Here immobilized, non-ligated partially duplex probes were used to capture and sequence short single-stranded targets. This strategy is capable of rapidly preparing large numbers of samples for future mass spectrometric DNA sequencing.


Subject(s)
DNA Probes , Nucleic Acid Hybridization , Sequence Analysis, DNA/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Base Sequence , Feasibility Studies , Molecular Sequence Data
14.
Proc Natl Acad Sci U S A ; 92(22): 10162-6, 1995 Oct 24.
Article in English | MEDLINE | ID: mdl-7479746

ABSTRACT

We have previously reported an enhanced version of sequencing by hybridization (SBH), termed positional SBH (PSBH). PSBH uses partially duplex probes containing single-stranded 3' overhangs, instead of simple single-stranded probes. Stacking interactions between the duplex probe and a single-stranded target allow us to reduce the probe sizes required to 5-base single-stranded overhangs. Here we demonstrate the use of PSBH to capture relatively long single-stranded DNA targets and perform standard solid-state Sanger sequencing on these primer-template complexes without ligation. Our results indicate that only 5 bases of known terminal sequence are required for priming. In addition, the partially duplex probes have the ability to capture their specific target from a mixture of five single-stranded targets with different 3'-terminal sequences. This indicates the potential utility of the PSBH approach to sequence mixtures of DNA targets without prior purification.


Subject(s)
Base Sequence , DNA Primers/chemistry , DNA, Single-Stranded/chemistry , DNA/chemistry , Genetic Techniques , Indicators and Reagents , Magnetics , Molecular Sequence Data , Polymerase Chain Reaction/methods
15.
Biochemistry ; 33(46): 13903-9, 1994 Nov 22.
Article in English | MEDLINE | ID: mdl-7524667

ABSTRACT

Two guanosine 2'-hydroxyls in the hammerhead RNA complex at positions G5 and G8 are critical for efficient cleavage by this RNA catalyst. These two functional groups are likely involved in the binding of the metal cofactor, or they are involved in specific interresidue hydrogen-bonding interactions. The importance of the stereochemical positioning of both critical 2'-hydroxyls was investigated by comparing the cleavage rates of three arabinosylguanine-substituted complexes (in which the positions of specific guanosine 2'-hydroxyls were stereochemically altered by inverting the C2' stereocenter) with that of the native complex, as well as with the rates of the dG- and dFG-substituted complexes [in which the 2'-hydroxyls are absent as the result of substitution by 2'-deoxyguanosine (dG) or 2'-deoxy-2'-fluoroguanosine (dFG)]. The G5araG and G8araG complexes exhibit dramatically different cleavage rates. The G5araG complex is essentially inactive, at least 10(5)-fold slower than the native complex. RNA cleavage by this analogue ribozyme is also 1000-fold slower than cleavage by either the G5dG or the G5dFG ribozyme, both of which lack the 2'-hydroxyl at G5. By comparison, catlytic efficiency of the G8araG complex as expressed by kcat/Km is comparable with that of the native complex and some 2 orders of magnitude more active than either the G8dG or the G8dFG complex.


Subject(s)
Deoxyguanosine/metabolism , RNA, Catalytic/metabolism , Arabinose/metabolism , Deoxyguanosine/analogs & derivatives , Hydroxyl Radical/metabolism , RNA/chemical synthesis , RNA/metabolism , RNA, Catalytic/chemistry , Stereoisomerism , Structure-Activity Relationship
16.
Biochemistry ; 32(40): 10629-37, 1993 Oct 12.
Article in English | MEDLINE | ID: mdl-8399208

ABSTRACT

Seven modified hammerhead ribozyme/substrate complexes have been prepared in which individual purine nitrogens, the guanine N7-, the guanine N2-, or the adenine N6-nitrogen, have been excised. The modified complexes were chemically synthesized with the substitution of a single 7-deazaguanosine (c7G), inosine (I), or nebularine (purine riboside, P) base analogue as appropriate for residues G5, G8, G12, A13, A14, or A15. Two of the base analogues, c7G5 and C7G8, occur in a 19-mer ribozyme, while the remaining three residues are present in a 24-mer substrate. Under stoichiometric conditions, four of the complexes, G5c7G, G8c7G, G12c7G, and A14P, are cleaved with relatively little change in rate when compared with the native complex. Two complexes, A13P and A15P, are cleaved some 6-8-fold slower than the native complex, while the G12I complex is reduced in rate by 50-fold. Steady-state kinetic analyses indicate that the cleavage efficiencies, as measured by kcat/KM values, for the G5c7G, G8c7G, and G12c7G complexes are only marginally reduced relative to the native complex. The values for the A13P, A14P, and A15P complexes are reduced by 25-, 15-, and 60-fold, respectively. These reductions in cleavage efficiency are primarily a result of lower kcat values. By comparison, the kcat/KM value for the G12I complex is decreased 450-fold relative to the native complex and is characterized by an 8-fold increase in KM and a kcat value that is reduced nearly 60-fold. These results indicate that the N2-amino group of G12 in the hammerhead ribozyme/substrate complex is critical for efficient cleavage activity.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Guanosine/metabolism , Nucleic Acid Conformation , Nucleosides/chemical synthesis , Nucleosides/metabolism , Purines/metabolism , RNA, Catalytic/metabolism , Amides , Base Composition , Base Sequence , Binding Sites , Guanosine/chemistry , Indicators and Reagents , Molecular Sequence Data , Nucleosides/chemistry , Phosphoric Acids , Purines/chemistry , RNA, Catalytic/chemistry
17.
Biochemistry ; 31(45): 10941-9, 1992 Nov 17.
Article in English | MEDLINE | ID: mdl-1445832

ABSTRACT

Five modified hammerhead ribozyme/substrate complexes have been prepared in which individual adenosine N7-nitrogens have been excised. The modified complexes were chemically synthesized with the substitution of a single 7-deazaadenosine (c7A) base analogue for residues A11, A14, A26, A27, or A28. Two of the base analogues, c7A11 and c7A14, occur in a 19-mer ribozyme, while the remaining three residues, c7A26, c7A27, and c7A28, are present in a 24-mer substrate. Under stoichiometric conditions, four of the complexes are cleaved with relatively little change in rate when compared with that of the native complex. However, the relative rate for the c7A11 complex is some 35-fold slower than that of the native complex. Steady-state kinetic analyses indicate that the cleavage efficiencies, as measured by kcat/KM, for the c7A14, c7A26, c7A27, and c7A28 complexes are reduced 18-fold, 10-fold, 34-fold, and 16-fold, respectively. These reductions in cleavage efficiency are primarily a result of lower kcat values. By comparison, the cleavage efficiency of the c7A11 complex is reduced more than 200-fold relative to that of the native complex, again primarily as a result of a lower kcat value. The results suggest that the N7-nitrogen of A11 in the hammerhead ribozyme/substrate complex is critical for efficient cleavage activity. The results of the present work, in combination with those from previous reports, indicate that five critical functional groups are located within the tetrameric sequence G10A11U12G13. A preliminary model for the binding of a single magnesium cofactor to this portion of the sequence is proposed.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Adenosine/chemistry , Magnesium/metabolism , Nitrogen/chemistry , RNA, Catalytic/metabolism , Binding Sites , Hydrolysis , Kinetics , Models, Molecular , Nucleic Acid Conformation , RNA, Catalytic/chemistry
18.
Proc Natl Acad Sci U S A ; 89(9): 3985-9, 1992 May 01.
Article in English | MEDLINE | ID: mdl-1570323

ABSTRACT

Eight modified ribozymes of 19 residues have been prepared with individual purine amino or hydroxyl groups excised. The modified ribozymes were chemically synthesized with the substitution of a single 2'-deoxyadenosine, 2'-deoxyguanosine, inosine, or purine riboside for residues G10, A11, G13, or A14. Five of the modified ribozymes cleaved the 24-mer substrate with little change in rate as monitored by simple first-order kinetics. However, deletion of the 2-amino group at G10 (replacement with inosine) or deletion of either of the 2'-hydroxyls at G10 or G13 (replacement with 2'-deoxyguanosine) resulted in ribozymes with a drastic decrease in cleavage efficiency. Increasing the concentration of the Mg2+ cofactor from 10 mM to 50 mM significantly enhanced cleavage efficiency by these three derivatives. Steady-state kinetic assays for these three ribozymes indicated that the modifications result in both an increase in Km and a decrease in kcat. These results suggest that the exocyclic amino group at-G10 and the hydroxyls at G10 and G13 are important both for ribozyme-substrate binding and for the Mg(2+)-catalyzed cleavage reaction.


Subject(s)
RNA, Catalytic/metabolism , Base Sequence , Hydrogen Bonding , Kinetics , Molecular Sequence Data , Oligonucleotides/chemistry , RNA, Catalytic/chemistry , Structure-Activity Relationship
19.
Hawaii Med J ; 50(3): 89-95, 1991 Mar.
Article in English | MEDLINE | ID: mdl-2061034

ABSTRACT

Although lead (Pb) is one of the oldest known and most thoroughly described toxins, it continues to be a significant health hazard in 1990. There has been much progress in defining the nature and extent of low-level lead toxicity during the past decade. There continues to be insidious sources of lead toxicity in our environment, in water, food, paint and contaminated soil. As the epidemiology of lead poisoning is more clearly defined, toxicities are recognized as the result of lower and lower levels of exposure. Recognition of low-level lead exposure and the primary prevention of its effects on health requires a keen awareness of high-risk environments as well as the subtle symptoms and signs of lead poisoning. A high index of suspicion by primary care physicians plus government support are necessary to implement successful prevention programs.


Subject(s)
Lead Poisoning/epidemiology , Child, Preschool , Cross-Sectional Studies , Hawaii/epidemiology , Humans , Incidence , Lead Poisoning/etiology , Lead Poisoning/prevention & control , Mass Screening
20.
Hawaii Med J ; 49(12): 467-8, 1990 Dec.
Article in English | MEDLINE | ID: mdl-1962763

ABSTRACT

Lead (Pb) is everywhere in our environment and all children are exposed to lead to some degree. The Center for Disease Control (CDC) has recently declared that a blood lead level of 25 micrograms/dL and an erythrocyte protophoryrin of 35 micrograms/dL or above indicate an excessive absorption of lead in children and constitutes grounds for intervention. A study reported that about 780,000 (4%) of American children age 6 months to 5 years had blood lead levels of 30 micrograms/dL or higher. If the current level of 25 micrograms/dL had been used as a criterion in this study, the number of children involved would be much higher. It has been clearly stated by the American Academy of Pediatrics that ideally, all pre-school children should be screened for lead absorption by means of the erythrocyte protophoryrin test. The following is a review of lead poisoning in children and the serious consequences which may follow if it is not recognized early.


Subject(s)
Lead Poisoning/epidemiology , Centers for Disease Control and Prevention, U.S. , Child , Child, Preschool , Humans , Lead Poisoning/blood , Lead Poisoning/therapy , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...